PeptideDB
de
EnglishEspañolDeutschPortuguês
PeptideKategorienVergleichLeitfädenGlossar

Prostamax

Moderates Forschungsinteresse

KEDP Tetrapeptide | Prostate Bioregulator

Sexuelle Gesundheit

Prostamax is a Khavinson bioregulator tetrapeptide (KEDP) with primary repair effects on prostate tissue. Developed by Professor Vladimir Khavinson at the St.

Molekulare und Forschungsdaten

Sequenz
Lys-Glu-Asp-Pro
Molekulargewicht
473 Da
Halbwertszeit
Not established
Wege (Forschung)
oral, injectable
Lagerung
Capsules at room temperature; reconstituted injectable at 2-8°C refrigerated

Overview

Prostamax is a Khavinson bioregulator tetrapeptide (KEDP) with primary repair effects on prostate tissue. Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it alters chromatin structure in cells from elderly individuals, promoting deheterochromatinization and potentially reactivating genes repressed during aging. Research in rat models shows reduced prostate inflammation, decreased swelling, and decelerated pathological remodeling associated with prostatitis.

Mechanism of action

Prostamax works through epigenetic regulation by altering chromatin structure. It increases the frequency of sister chromatid exchanges and Ag-positive nucleolar organizer regions (NORs), while reducing large segments of pericentromeric heterochromatin. These changes promote chromatin decondensation and deheterochromatinization, potentially reactivating genes repressed during aging. The peptide influences heterochromatin arrangements in human lymphocytes and normalizes age-related changes in cellular function.

Key research findings

  • Reduces prostate inflammation
  • Decreases prostatic swelling
  • Reduces vascular congestion (hyperemia)
  • Decreases immune cell infiltration
  • Reduces scarring in prostate tissue
  • Promotes chromatin decondensation
  • Reactivates age-repressed genes
  • Improves lymphocyte function

Research applications

Prostate Health

  • Chronic Prostatitis — Research shows reduced inflammation and swelling in prostatitis models.
  • Prostatic Inflammation — Mitigates inflammation and immune cell infiltration in prostate tissue.
  • Prostate Tissue Repair — Decreases scarring and pathological remodeling in prostate.

Anti-Aging

  • Chromatin Remodeling — Promotes deheterochromatinization in elderly cells.
  • Gene Reactivation — Potentially reactivates genes repressed during aging process.
  • Lymphocyte Function — Normalizes age-related changes in lymphocyte function.

Prostamax Häufig gestellte Fragen

Is Prostamax safe to take if I have a family history of prostate cancer?+

No. The safety flags include 'carcinogenic-risk,' and the contraindications explicitly state you should consult an oncologist if you have prostate cancer. While Prostamax targets benign prostate conditions, the carcinogenic-risk flag suggests unknown interactions with cancer development. Family history warrants professional medical consultation before use.

How does Prostamax reduce prostate swelling without hormone manipulation?+

Prostamax works through epigenetic chromatin remodeling—it alters the physical structure of chromatin by increasing sister chromatid exchanges and decreasing heterochromatin. This promotes 'deheterochromatinization,' reactivating genes silenced during aging. It doesn't block hormones; it resets gene expression patterns in prostate cells.

Can Prostamax help with benign prostatic hyperplasia (BPH)?+

Yes. Animal studies show Prostamax reduces prostate inflammation, swelling, and scarring—the key pathologies in BPH. However, these are preclinical results in rats. Human clinical trials are absent. If you have BPH, discuss with your urologist about whether Prostamax might complement standard treatments like alpha-blockers.

Should I get a PSA test before starting Prostamax?+

Yes. The file recommends PSA testing for men over 50 before use. This is essential to establish a baseline and rule out prostate cancer before starting. Repeat PSA testing during treatment is prudent, especially given the carcinogenic-risk flag in the pharmacology section.

References

  1. [1]Experimental Studying of Drug Efficiency Prostamax in Therapy of Chronic Aseptic ProstatitisBulletin of Experimental Biology and Medicine
  2. [2]Effects of Short Peptides on Lymphocyte Chromatin in Senile SubjectsBulletin of Experimental Biology and Medicine
  3. [3]Deheterochromatinization of Chromatin in Old Age Induced by Oligopeptide Bioregulator (Lys-Glu-Asp-Pro)Georgian Medical News
  4. [4]Khavinson Peptide BioregulatorsAdvances in Gerontology

Verwandte Peptide

Gonadorelin

Extensively studied

Gonadotropin-Releasing Hormone | GnRH Agonist

Gonadorelin is a synthetic form of the naturally occurring gonadotropin-releasing hormone (GnRH).

Sexuelle GesundheitHormonell

HCG

FDA-approved

Human Chorionic Gonadotropin | LH Receptor Agonist

HCG is a glycoprotein hormone naturally produced by the placenta during pregnancy that binds LH receptors to stimulate testosterone and estrogen biosynthesis.

Sexuelle GesundheitHormonell

HMG

Extensively studied

Human Menopausal Gonadotropin | FSH/LH Fertility Hormone

Human Menopausal Gonadotropin (HMG) is a hormonally active medication containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in a 1:1 ratio, extracted from the urine of

Sexuelle GesundheitHormonell

Kisspeptin

Emerging research

KISS1 Gene Product | Reproductive Neuropeptide

Kisspeptin acts as a master regulator of the reproductive system, stimulating GnRH neurons essential for puberty, fertility, and reproductive function.

Sexuelle GesundheitHormonell